Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...
(Yicai) March 23 -- For more than a decade, the promise of artificial intelligence in biotechnology has centered on discovery ...
One year of setmelanotide provided reductions in BMI z score for children and body weight for adults with Bardet-Biedl ...
Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung ...
Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference PARIS and CAMBRIDGE, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company” ...
AI-Evolved Adaptive Robot Is Nearly Impossible to Destroy Robots have long been designed around a simple assumption: their bodies and ...
A major randomized trial challenges the assumed benefit of tumor debulking in advanced colorectal cancer, showing no survival gain despite increased risks and raising questions about its role in ...
LAS VEGAS -- A group prenatal care program that was informed by members of the community diminished postpartum depression among pregnant people, the EleVATE randomized controlled trial showed. Moms ...
Recent regulatory setbacks, especially involving Asia-centric trials, underscore the consequences of insufficient regional planning. Emerging statistical approaches, including adaptive and Bayesian ...
AUSTIN, Texas--(BUSINESS WIRE)--Berry Consultants, LLC announced the release of FACTS 8, the latest version of its industry-leading Fixed and Adaptive Clinical Trial Simulator (FACTS). FACTS 8 is now ...
AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced the publication in peer-reviewed journal Nature Medicine of 12-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results